RAYNE ROUCE to Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
This is a "connection" page, showing publications RAYNE ROUCE has written about Precursor T-Cell Lymphoblastic Leukemia-Lymphoma.
Connection Strength
0.240
-
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies. Blood. 2017 07 20; 130(3):285-296.
Score: 0.128
-
A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies. Blood. 2015 Aug 20; 126(8):983-92.
Score: 0.112